Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial
Conditions: Hepatocellular Carcinoma Interventions: Biological: Autologous Dendritic Cell Sponsors: Chang Gung Memorial Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Hospitals | Liver | Liver Cancer | Research | Urology & Nephrology | Vaccines